Two Melbourne entrepreneurs who helped bring the first rapid antigen tests to Australia during the pandemic are targeting Asia with a supplement aimed at improving cognitive performance, health and longevity.
Biotech company Longevity Life Sciences, founded by Sally Panton, 36, and Lucy Canny, 25, raised early investment from Myer Walker HK, the Hong Kong-based investment firm co-founded by Ed Myer of the Myer family, which owns a stake in the company. Fiona Myer is also an investor. LLS was recently valued at $US60 million ($90 million).
